Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Critically Ill
and you are
The phase for this study is not defined.
Show me locations

The purpose

Vancomycin is a glycopeptide antibiotic that is the first line antibiotics for the treatment of serious gram-positive infections involving methicillin-resistant Staphylococcus aureus (MRSA). Its therapeutic window is narrow, so there is a need to monitor serum vancomycin concentration in clinical practice, especially in the critically ill patients. So far, few studies have investigated the clinical outcomes of the dosage strategy that vancomycin dosage is administered and adjusted individually using PPK and Bayesian methods based on observed concentrations. The objective of this study is to investigate the effectiveness, safety and economics of the vancomycin individualized dosing service provided by pharmacists.

Provided treatments

  • Other: Pharmacists consultation
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02896218. The sponsor of the trial is Peking University Third Hospital and it is looking for 400 volunteers for the current phase.
Official trial title:
Therapeutic Monitoring of Vancomycin in Critical Ill Patients: a Registry